Public list: Pharma Startups (4733) Cancer Therapeutics (1136)
Jounce Therapeutics is dedicated to transforming the treatment of cancer through discovering and developing novel cancer immunotherapies with the potential to drive significantly more durable responses to treatment, extending and improving patients' ...Show all
Company (IPO / Went public)
Phone: 857-259-3840
1030 Massachusetts Ave
Cambridge, 02138
Massachusetts, United States
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Antibodies to pd-1 and uses thereof | Nov 01, 2017 | Application | |
| Antibodies to icos | Mar 22, 2016 | Application | |
| Antibodies that inhibit tim-3:lilrb2 interactions and uses thereof | Jan 04, 2016 | Application | |
| Methods of treating conditions with antibodies that bind b7-h4 | Oct 30, 2015 | Application |
Download PDF